Approval · Notice of Compliance 30089 · 2023
VALPROIC ACID: Notice of Compliance 30089
Issued February 9, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30089
- Date
- February 9, 2023
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to The Product Monograph
- Canadian reference product
- DEPAKENE (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALPROIC ACID | Not yet assigned | — |
| VALPROIC ACID ORAL SOLUTION | Not yet assigned | — |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 250 MG per 5ML